Ash Bullement
Nottingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Use of external data to inform overall survival extrapolation in NICE technology appraisals for oncology drugs.
Journal: Journal of medical economics
Published: May 20, 2025
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.
Journal: Future oncology (London, England)
Published: May 19, 2025
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation-A Tutorial.
Journal: PharmacoEconomics
Published: August 11, 2024
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.
Journal: Future oncology (London, England)
Published: August 02, 2023
Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach.
Journal: BMC cancer
Published: July 18, 2023
A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: May 01, 2023
A UK cost-effectiveness analysis of trifluridine/tipiracil for heavily pretreated metastatic gastroesophageal cancers.
Journal: Future oncology (London, England)
Published: April 28, 2023
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology.
Journal: Applied health economics and health policy
Published: January 22, 2023
Last Updated: 09/26/2026